Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS Hosted
Latest MIMS news
Drug information trackers
Drug shortages - live tracker
Use our constantly updated shortages tracker to check...
New products - live tracker
EXCLUSIVE TO SUBSCRIBERS See the latest products added...
Drug price changes - live tracker
EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...
New and deleted indications - live tracker
EXCLUSIVE TO SUBSCRIBERS See the latest changes to...
Products coming soon - live tracker
EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...
Deleted products - live tracker
EXCLUSIVE TO SUBSCRIBERS See the latest products removed...
Most popular
Hormone replacement therapy (HRT)
Hormone doses and costs of HRT preparations.
NSAIDs analgesic of choice for osteoarthritis in draft NICE guidance
The draft guidance recommends that people with osteoarthritis...
Antidepressants, a guide to switching and withdrawing
Instructions for changing or stopping antidepressants.
Contraceptives, oral and transdermal preparations
Hormone doses and costs of hormonal contraceptives.
HRT products limited to three-month supply
The dispensing of three HRT products is temporarily...
Inhaler carbon emissions
NEW | Carbon footprints of asthma and COPD inhalers.
MIMS Connect
Promoted
Established muscle relaxant offers new approach to managing back pain
Sponsored by Mibe Pharma
A muscle relaxant that has been used for decades outside the UK may provide an alternative to current treatments for low back pain, explains Dr Sunny Nayee, consultant in anaesthesia and pain medicine at Imperial College NHS Healthcare Trust.
Sponsored by Mibe Pharma UK Ltd. UK/MYO/21/044; December 2021.
Click here to view prescribing information for Myopridin® (pridinol mesilate)
Featured MIMS resources
Table: Inhaler carbon emissions
Carbon footprints of asthma and COPD inhalers.
Guideline: Irritable bowel syndrome
Summary of NICE guidance on IBS.
MIMS Tables
At-a-glance drug comparison charts including dosing and monitoring regimens, available presentations, prices, potential sensitisers and compatible devices.
- Antidepressants - switching/withdrawing
- Antidiabetic agents, use in renal impairment
- Contraceptives: oral and transdermal
- Asthma & COPD preparations
- COVID-19 vaccines
- Dry eye treatments
- Emollients containing urea
- GLP-1 agonists for type II diabetes
- Hayfever treatments
- Hormone replacement therapy (HRT)
- Inhaler carbon emissions
- Infant formulae
- Initiating combined hormonal contraceptives
- Migraine treatments and prophylactics
Click here for full list of tables
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.